Poor prognostic factors in relapsed or refractory Hodgkin lymphoma
Patient group . | Factor . |
---|---|
Relapsed | Time to relapse < 1 year18,21-24 |
Stage III-IV (IV: Lohri, Martin)18,19,21,22,24 | |
Anemia18 | |
B symptoms21,24 | |
Poor performance status23 | |
Refractory | Poor performance status17,23 |
Age > 50 y17 | |
Failure to attain a temporary remission17 | |
B symptoms21 | |
Stage III-IV (IV: Martin)19,21 | |
ASCT | Previously untreated relapse23 |
Response to chemotherapy19 | |
Low serum albumin25 | |
Anemia25 | |
Age25 | |
Lymphocytopenia25 | |
B symptoms26 | |
Extranodal disease26 | |
Time to relapse < 1 year26 | |
Disease status at ASCT20 | |
Disease relapse in previous radiation field20 |
Patient group . | Factor . |
---|---|
Relapsed | Time to relapse < 1 year18,21-24 |
Stage III-IV (IV: Lohri, Martin)18,19,21,22,24 | |
Anemia18 | |
B symptoms21,24 | |
Poor performance status23 | |
Refractory | Poor performance status17,23 |
Age > 50 y17 | |
Failure to attain a temporary remission17 | |
B symptoms21 | |
Stage III-IV (IV: Martin)19,21 | |
ASCT | Previously untreated relapse23 |
Response to chemotherapy19 | |
Low serum albumin25 | |
Anemia25 | |
Age25 | |
Lymphocytopenia25 | |
B symptoms26 | |
Extranodal disease26 | |
Time to relapse < 1 year26 | |
Disease status at ASCT20 | |
Disease relapse in previous radiation field20 |
ASCT indicates autologous stem cell transplant.